SUBSCRIBE
SUBSCRIBE
Biotech Bay

Affymax, Inc. to Present at UBS Warburg Global Life Sciences Conference

September 17, 2008 | 
1 min read

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (NASDAQ: AFFY) today announced that management will present at the 2008 UBS Global Life Sciences Conference on Thursday, September 25, 2008, at 1:00 p.m. ET at the Grand Hyatt New York.

Events
MORE ON THIS TOPIC
Pictured: AstraZeneca building in Gothenburg/iStoc
Bladder cancer
AstraZeneca’s Perioperative Imfinzi ‘Significantly Extends Survival’ in Type of Bladder Cancer
September 16, 2024
 · 
2 min read
 · 
Tristan Manalac
GSK's headquarters in West London
Lung cancer
GSK, iTeos Score Phase II Win for Jemperli-TIGIT Combo in NSCLC
September 16, 2024
 · 
2 min read
 · 
Tristan Manalac
Aerial view of the coastal area of Barcelona overlooking Olympic Harbor marina
Cancer
ESMO 2024 Preview: Bispecifics and TIGITs Among the Hottest Topics in Oncology
September 9, 2024
 · 
4 min read
 · 
Heather McKenzie
Rajesh Misra, Principal, Life Sciences Quality and Regulatory, KPMG; Denise Mead, Healthcare and Life Sciences Technology Leader, Microsoft; Don Soong, Sr. Director/GM, QARA and Spend Transparency Solutions, IQVIA
Partnered
QARA Professionals Question a Future with Cybersecurity Issues, US Litigation, and the EU AI Act
August 12, 2024
 · 
8 min read
 · 
BioSpace Insights